Elite Express Holding Inc. 8-K

What Happened

• Elite Express Holding Inc. (ETS) filed an 8-K reporting that on April 30, 2026 Nasdaq notified the company it has not regained compliance with Nasdaq Listing Rule 5550(a)(2) (minimum $1.00 bid price) but is eligible for an additional 180-day compliance period through October 26, 2026.
• Nasdaq’s extension follows an initial deficiency letter dated October 31, 2025, which gave the company until April 29, 2026 to cure the deficiency. Nasdaq noted the company meets the market value of publicly held shares and other initial listing requirements aside from the bid price.

Key Details

• Deficiency first notified: October 31, 2025; initial cure deadline: April 29, 2026.
• Second Compliance Period granted: 180 days from April 30, 2026, ending October 26, 2026.
• Compliance can be achieved if the closing bid price is at least $1.00 for a minimum of 10 consecutive business days (subject to Nasdaq discretion).
• The company may consider a reverse stock split (within a previously stockholder-approved ratio) to regain compliance; Nasdaq’s notice does not affect current listing or trading.

Why It Matters

• If ETS does not regain the $1.00 bid-price compliance by October 26, 2026, Nasdaq will notify the company that its securities will be subject to delisting, which could materially affect liquidity and shareholder value.
• A reverse stock split, if used, would reduce the number of outstanding shares and raise the per-share price, changing share counts and per-share metrics for investors.
• Retail investors should monitor ETS’s stock price, company announcements, and any proxy or shareholder votes related to reverse split authority or other remediation plans.